Inspire Medical announces publication of results for Inspire therapy study
Inspire Medical announced the publication of clinical results comparing the effects of Inspire therapy on Medicare-aged patients to younger patients. The study, led by physicians at the University of Alabama at Birmingham, followed 235 Medicare-aged patients and 365 younger-aged patients and collected information regarding sleep apnea severity, quality of life and any complications with the procedure. The results of the study demonstrated that while all patients positively responded to Inspire therapy, the Medicare-aged patients had both a slightly higher response, as well as a slightly higher adherence, to therapy. The study noted that an age equal to or greater than 65 years is an independent factor for success with Inspire therapy as compared with younger cohorts. The paper concluded that Inspire therapy should be considered in the treatment of older patients who are CPAP intolerant and eligible per the established inclusion criteria.